The symptom burden of Irritable Bowel Syndrome in tertiary care during the COVID‐19 pandemic

Background The COVID‐19 pandemic caused unprecedented disruption to healthcare services worldwide with well‐documented detrimental effects on mental health. Patients with refractory disorders of gut‐brain interaction such as Irritable Bowel Syndrome (IBS) seen in tertiary care tend to exhibit higher...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Neurogastroenterology and motility 2022-09, Vol.34 (9), p.e14347-n/a
Hauptverfasser: Noble, Hithin, Hasan, Syed Shariq, Whorwell, Peter J., Vasant, Dipesh H.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page n/a
container_issue 9
container_start_page e14347
container_title Neurogastroenterology and motility
container_volume 34
creator Noble, Hithin
Hasan, Syed Shariq
Whorwell, Peter J.
Vasant, Dipesh H.
description Background The COVID‐19 pandemic caused unprecedented disruption to healthcare services worldwide with well‐documented detrimental effects on mental health. Patients with refractory disorders of gut‐brain interaction such as Irritable Bowel Syndrome (IBS) seen in tertiary care tend to exhibit higher levels of psychological comorbidity, but the impact of the pandemic on IBS symptom severity in tertiary care is unknown. Methods As part of routine clinical care, consecutive tertiary referrals with refractory IBS patients prospectively completed a series of baseline questionnaires including IBS symptom severity score (IBS‐SSS), non‐colonic symptom score, Hospital Anxiety and Depression (HAD), and Illness impact scores. The symptom severity questionnaire data were compared for consecutive patients seen in tertiary care 12 months before and after the onset of COVID‐19 pandemic restrictions. Key Results Of 190 consecutive tertiary referrals with IBS, those seen during the pandemic had greater IBS severity (IBS‐SSS: 352 vs. 318, p = 0.03), more severe extra‐intestinal symptoms (non‐colonic score: 269 vs. 225, p = 0.03), sleep difficulties (p = 0.03), helplessness and loss of control (p = 0.02), but similar HAD‐Anxiety (p = 0.96) and HAD‐Depression (p = 0.84) scores. During the pandemic, unmarried patients (p = 0.03), and keyworkers (p = 0.0038) had greater IBS severity. Conclusions and Inferences This study has shown for the first time that patients seen in tertiary care with refractory IBS during the COVID‐19 pandemic had a significantly higher symptom burden emphasizing the importance of gut‐brain axis in IBS. Furthermore, lack of support and perceived loss of control appear to be contributory factors. Consecutive patients with Irritable Bowel Syndrome assessed in a tertiary center during the first 12‐months of COVID‐19 pandemic restrictions had significantly greater gastrointestinal and extra‐intestinal symptom severities compared to those seen during the 12‐months before the pandemic.
doi_str_mv 10.1111/nmo.14347
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9115346</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2635475897</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4437-d245af3761faf9a8a4271eaef815ee5ebcc9ba889a6e1d59ba0ffe7fa05d6b33</originalsourceid><addsrcrecordid>eNp1kctu1DAUhi0EoqWw4AWQJTZ0kdbX2NkgwZTLSIVZMGKJ5STHravEntoJ1ex4BJ6RJ8HDlAqQOJtzJH_69Fs_Qk8pOaFlTsMYT6jgQt1Dh5TXsmKNZvd3tyQVbZg8QI9yviKE1EzUD9EBl4xrwfQh-rK-BJy342aKI27n1EPA0eFlSn6y7QD4dbyBAX_ahj7FEbAPeII0eZu2uLMJcD8nHy7wVDSL1efl2Y9v32mDNzb0MPruMXrg7JDhye0-Quu3b9aL99X56t1y8eq86oTgquqZkNZxVVNnXWO1FUxRsOA0lQAS2q5rWqt1Y2ugvSw3cQ6Us0T2dcv5EXq5127mdoS-gzAlO5hN8mMJaqL15u-X4C_NRfxqGkolF3URvLgVpHg9Q57M6HMHw2ADxDkbVnMplNSNKujzf9CrOKdQfmeYIkoozfSOOt5TXYo5J3B3YSgxu9JMKc38Kq2wz_5Mf0f-bqkAp3vgxg-w_b_JfPyw2it_AlRSo2Q</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2707478287</pqid></control><display><type>article</type><title>The symptom burden of Irritable Bowel Syndrome in tertiary care during the COVID‐19 pandemic</title><source>Wiley Free Content</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Noble, Hithin ; Hasan, Syed Shariq ; Whorwell, Peter J. ; Vasant, Dipesh H.</creator><creatorcontrib>Noble, Hithin ; Hasan, Syed Shariq ; Whorwell, Peter J. ; Vasant, Dipesh H.</creatorcontrib><description>Background The COVID‐19 pandemic caused unprecedented disruption to healthcare services worldwide with well‐documented detrimental effects on mental health. Patients with refractory disorders of gut‐brain interaction such as Irritable Bowel Syndrome (IBS) seen in tertiary care tend to exhibit higher levels of psychological comorbidity, but the impact of the pandemic on IBS symptom severity in tertiary care is unknown. Methods As part of routine clinical care, consecutive tertiary referrals with refractory IBS patients prospectively completed a series of baseline questionnaires including IBS symptom severity score (IBS‐SSS), non‐colonic symptom score, Hospital Anxiety and Depression (HAD), and Illness impact scores. The symptom severity questionnaire data were compared for consecutive patients seen in tertiary care 12 months before and after the onset of COVID‐19 pandemic restrictions. Key Results Of 190 consecutive tertiary referrals with IBS, those seen during the pandemic had greater IBS severity (IBS‐SSS: 352 vs. 318, p = 0.03), more severe extra‐intestinal symptoms (non‐colonic score: 269 vs. 225, p = 0.03), sleep difficulties (p = 0.03), helplessness and loss of control (p = 0.02), but similar HAD‐Anxiety (p = 0.96) and HAD‐Depression (p = 0.84) scores. During the pandemic, unmarried patients (p = 0.03), and keyworkers (p = 0.0038) had greater IBS severity. Conclusions and Inferences This study has shown for the first time that patients seen in tertiary care with refractory IBS during the COVID‐19 pandemic had a significantly higher symptom burden emphasizing the importance of gut‐brain axis in IBS. Furthermore, lack of support and perceived loss of control appear to be contributory factors. Consecutive patients with Irritable Bowel Syndrome assessed in a tertiary center during the first 12‐months of COVID‐19 pandemic restrictions had significantly greater gastrointestinal and extra‐intestinal symptom severities compared to those seen during the 12‐months before the pandemic.</description><identifier>ISSN: 1350-1925</identifier><identifier>EISSN: 1365-2982</identifier><identifier>DOI: 10.1111/nmo.14347</identifier><identifier>PMID: 35238428</identifier><language>eng</language><publisher>England: Wiley Subscription Services, Inc</publisher><subject>Anxiety ; Comorbidity ; COVID-19 ; COVID‐19 pandemic ; Digestive system ; disorders of gut‐brain interaction ; Gastrointestinal tract ; Health care ; Intestine ; Irritable Bowel Syndrome ; Mental depression ; Original ; Pandemics ; Patients</subject><ispartof>Neurogastroenterology and motility, 2022-09, Vol.34 (9), p.e14347-n/a</ispartof><rights>2022 The Authors. published by John Wiley &amp; Sons Ltd.</rights><rights>2022 The Authors. Neurogastroenterology &amp; Motility published by John Wiley &amp; Sons Ltd.</rights><rights>2022. This article is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4437-d245af3761faf9a8a4271eaef815ee5ebcc9ba889a6e1d59ba0ffe7fa05d6b33</citedby><cites>FETCH-LOGICAL-c4437-d245af3761faf9a8a4271eaef815ee5ebcc9ba889a6e1d59ba0ffe7fa05d6b33</cites><orcidid>0000-0002-5220-8474 ; 0000-0002-2329-0616</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fnmo.14347$$EPDF$$P50$$Gwiley$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fnmo.14347$$EHTML$$P50$$Gwiley$$Hfree_for_read</linktohtml><link.rule.ids>230,314,776,780,881,1411,1427,27901,27902,45550,45551,46384,46808</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35238428$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Noble, Hithin</creatorcontrib><creatorcontrib>Hasan, Syed Shariq</creatorcontrib><creatorcontrib>Whorwell, Peter J.</creatorcontrib><creatorcontrib>Vasant, Dipesh H.</creatorcontrib><title>The symptom burden of Irritable Bowel Syndrome in tertiary care during the COVID‐19 pandemic</title><title>Neurogastroenterology and motility</title><addtitle>Neurogastroenterol Motil</addtitle><description>Background The COVID‐19 pandemic caused unprecedented disruption to healthcare services worldwide with well‐documented detrimental effects on mental health. Patients with refractory disorders of gut‐brain interaction such as Irritable Bowel Syndrome (IBS) seen in tertiary care tend to exhibit higher levels of psychological comorbidity, but the impact of the pandemic on IBS symptom severity in tertiary care is unknown. Methods As part of routine clinical care, consecutive tertiary referrals with refractory IBS patients prospectively completed a series of baseline questionnaires including IBS symptom severity score (IBS‐SSS), non‐colonic symptom score, Hospital Anxiety and Depression (HAD), and Illness impact scores. The symptom severity questionnaire data were compared for consecutive patients seen in tertiary care 12 months before and after the onset of COVID‐19 pandemic restrictions. Key Results Of 190 consecutive tertiary referrals with IBS, those seen during the pandemic had greater IBS severity (IBS‐SSS: 352 vs. 318, p = 0.03), more severe extra‐intestinal symptoms (non‐colonic score: 269 vs. 225, p = 0.03), sleep difficulties (p = 0.03), helplessness and loss of control (p = 0.02), but similar HAD‐Anxiety (p = 0.96) and HAD‐Depression (p = 0.84) scores. During the pandemic, unmarried patients (p = 0.03), and keyworkers (p = 0.0038) had greater IBS severity. Conclusions and Inferences This study has shown for the first time that patients seen in tertiary care with refractory IBS during the COVID‐19 pandemic had a significantly higher symptom burden emphasizing the importance of gut‐brain axis in IBS. Furthermore, lack of support and perceived loss of control appear to be contributory factors. Consecutive patients with Irritable Bowel Syndrome assessed in a tertiary center during the first 12‐months of COVID‐19 pandemic restrictions had significantly greater gastrointestinal and extra‐intestinal symptom severities compared to those seen during the 12‐months before the pandemic.</description><subject>Anxiety</subject><subject>Comorbidity</subject><subject>COVID-19</subject><subject>COVID‐19 pandemic</subject><subject>Digestive system</subject><subject>disorders of gut‐brain interaction</subject><subject>Gastrointestinal tract</subject><subject>Health care</subject><subject>Intestine</subject><subject>Irritable Bowel Syndrome</subject><subject>Mental depression</subject><subject>Original</subject><subject>Pandemics</subject><subject>Patients</subject><issn>1350-1925</issn><issn>1365-2982</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><recordid>eNp1kctu1DAUhi0EoqWw4AWQJTZ0kdbX2NkgwZTLSIVZMGKJ5STHravEntoJ1ex4BJ6RJ8HDlAqQOJtzJH_69Fs_Qk8pOaFlTsMYT6jgQt1Dh5TXsmKNZvd3tyQVbZg8QI9yviKE1EzUD9EBl4xrwfQh-rK-BJy342aKI27n1EPA0eFlSn6y7QD4dbyBAX_ahj7FEbAPeII0eZu2uLMJcD8nHy7wVDSL1efl2Y9v32mDNzb0MPruMXrg7JDhye0-Quu3b9aL99X56t1y8eq86oTgquqZkNZxVVNnXWO1FUxRsOA0lQAS2q5rWqt1Y2ugvSw3cQ6Us0T2dcv5EXq5127mdoS-gzAlO5hN8mMJaqL15u-X4C_NRfxqGkolF3URvLgVpHg9Q57M6HMHw2ADxDkbVnMplNSNKujzf9CrOKdQfmeYIkoozfSOOt5TXYo5J3B3YSgxu9JMKc38Kq2wz_5Mf0f-bqkAp3vgxg-w_b_JfPyw2it_AlRSo2Q</recordid><startdate>202209</startdate><enddate>202209</enddate><creator>Noble, Hithin</creator><creator>Hasan, Syed Shariq</creator><creator>Whorwell, Peter J.</creator><creator>Vasant, Dipesh H.</creator><general>Wiley Subscription Services, Inc</general><general>John Wiley and Sons Inc</general><scope>24P</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>K9.</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-5220-8474</orcidid><orcidid>https://orcid.org/0000-0002-2329-0616</orcidid></search><sort><creationdate>202209</creationdate><title>The symptom burden of Irritable Bowel Syndrome in tertiary care during the COVID‐19 pandemic</title><author>Noble, Hithin ; Hasan, Syed Shariq ; Whorwell, Peter J. ; Vasant, Dipesh H.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4437-d245af3761faf9a8a4271eaef815ee5ebcc9ba889a6e1d59ba0ffe7fa05d6b33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Anxiety</topic><topic>Comorbidity</topic><topic>COVID-19</topic><topic>COVID‐19 pandemic</topic><topic>Digestive system</topic><topic>disorders of gut‐brain interaction</topic><topic>Gastrointestinal tract</topic><topic>Health care</topic><topic>Intestine</topic><topic>Irritable Bowel Syndrome</topic><topic>Mental depression</topic><topic>Original</topic><topic>Pandemics</topic><topic>Patients</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Noble, Hithin</creatorcontrib><creatorcontrib>Hasan, Syed Shariq</creatorcontrib><creatorcontrib>Whorwell, Peter J.</creatorcontrib><creatorcontrib>Vasant, Dipesh H.</creatorcontrib><collection>Wiley Online Library Open Access</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Neurogastroenterology and motility</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Noble, Hithin</au><au>Hasan, Syed Shariq</au><au>Whorwell, Peter J.</au><au>Vasant, Dipesh H.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The symptom burden of Irritable Bowel Syndrome in tertiary care during the COVID‐19 pandemic</atitle><jtitle>Neurogastroenterology and motility</jtitle><addtitle>Neurogastroenterol Motil</addtitle><date>2022-09</date><risdate>2022</risdate><volume>34</volume><issue>9</issue><spage>e14347</spage><epage>n/a</epage><pages>e14347-n/a</pages><issn>1350-1925</issn><eissn>1365-2982</eissn><abstract>Background The COVID‐19 pandemic caused unprecedented disruption to healthcare services worldwide with well‐documented detrimental effects on mental health. Patients with refractory disorders of gut‐brain interaction such as Irritable Bowel Syndrome (IBS) seen in tertiary care tend to exhibit higher levels of psychological comorbidity, but the impact of the pandemic on IBS symptom severity in tertiary care is unknown. Methods As part of routine clinical care, consecutive tertiary referrals with refractory IBS patients prospectively completed a series of baseline questionnaires including IBS symptom severity score (IBS‐SSS), non‐colonic symptom score, Hospital Anxiety and Depression (HAD), and Illness impact scores. The symptom severity questionnaire data were compared for consecutive patients seen in tertiary care 12 months before and after the onset of COVID‐19 pandemic restrictions. Key Results Of 190 consecutive tertiary referrals with IBS, those seen during the pandemic had greater IBS severity (IBS‐SSS: 352 vs. 318, p = 0.03), more severe extra‐intestinal symptoms (non‐colonic score: 269 vs. 225, p = 0.03), sleep difficulties (p = 0.03), helplessness and loss of control (p = 0.02), but similar HAD‐Anxiety (p = 0.96) and HAD‐Depression (p = 0.84) scores. During the pandemic, unmarried patients (p = 0.03), and keyworkers (p = 0.0038) had greater IBS severity. Conclusions and Inferences This study has shown for the first time that patients seen in tertiary care with refractory IBS during the COVID‐19 pandemic had a significantly higher symptom burden emphasizing the importance of gut‐brain axis in IBS. Furthermore, lack of support and perceived loss of control appear to be contributory factors. Consecutive patients with Irritable Bowel Syndrome assessed in a tertiary center during the first 12‐months of COVID‐19 pandemic restrictions had significantly greater gastrointestinal and extra‐intestinal symptom severities compared to those seen during the 12‐months before the pandemic.</abstract><cop>England</cop><pub>Wiley Subscription Services, Inc</pub><pmid>35238428</pmid><doi>10.1111/nmo.14347</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0002-5220-8474</orcidid><orcidid>https://orcid.org/0000-0002-2329-0616</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1350-1925
ispartof Neurogastroenterology and motility, 2022-09, Vol.34 (9), p.e14347-n/a
issn 1350-1925
1365-2982
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9115346
source Wiley Free Content; Wiley Online Library Journals Frontfile Complete
subjects Anxiety
Comorbidity
COVID-19
COVID‐19 pandemic
Digestive system
disorders of gut‐brain interaction
Gastrointestinal tract
Health care
Intestine
Irritable Bowel Syndrome
Mental depression
Original
Pandemics
Patients
title The symptom burden of Irritable Bowel Syndrome in tertiary care during the COVID‐19 pandemic
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-11T10%3A20%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20symptom%20burden%20of%20Irritable%20Bowel%20Syndrome%20in%20tertiary%20care%20during%20the%20COVID%E2%80%9019%20pandemic&rft.jtitle=Neurogastroenterology%20and%20motility&rft.au=Noble,%20Hithin&rft.date=2022-09&rft.volume=34&rft.issue=9&rft.spage=e14347&rft.epage=n/a&rft.pages=e14347-n/a&rft.issn=1350-1925&rft.eissn=1365-2982&rft_id=info:doi/10.1111/nmo.14347&rft_dat=%3Cproquest_pubme%3E2635475897%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2707478287&rft_id=info:pmid/35238428&rfr_iscdi=true